4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-058075
Chief Financial Officer sold 43,505 shares at an average $69.37 ($3,018,071)
- Chief Financial Officer acquired 43,505 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myszkowski Kenneth Allen Chief Financial Officer | 2020-11-09 | Option exercise | +43,505 | $14.54 | $632,563 | 471,173 | D |
| Myszkowski Kenneth Allen Chief Financial Officer | 2020-11-09 | Sale | −25,840 | $69.04 | $1,783,994 | 445,333 | D |
| Myszkowski Kenneth Allen Chief Financial Officer | 2020-11-09 | Sale | −17,665 | $69.86 | $1,234,077 | 427,668 | D |
| Derivatives | |||||||
| Myszkowski Kenneth Allen Chief Financial Officer | 2020-11-09 | Option exercise · Stock Option (right to buy) | −43,505 | 0 | D | ||
| Open-market sales · 43,505 sh · avg $69.37 · $3,018,071 | |||||||
Loading xslF345X03/doc4.xml…